Core Viewpoint - Fuxiang Pharmaceutical has recently obtained an invention patent certificate from the Korean Intellectual Property Office for the application of "short-stemmed fusarium in the production of mycelial protein" [2] Company Summary - The patent awarded to Fuxiang Pharmaceutical is significant as it highlights the company's innovation in utilizing short-stemmed fusarium for producing mycelial protein, which may enhance its product offerings and competitive edge in the pharmaceutical industry [2]